BIOEQUIVALANCE
Clinical trials for BIOEQUIVALANCE explained in plain language.
Never miss a new study
Get alerted when new BIOEQUIVALANCE trials appear
Sign up with your email to follow new studies for BIOEQUIVALANCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Healthy volunteers test generic vs. brand drug equivalence
Knowledge-focused CompletedThis study checked if two different oral versions of vortioxetine 20 mg tablets are absorbed the same way in the body. Twenty healthy adults aged 18 to 55 took a single dose of each version in a random order. The goal was to measure drug levels in the blood, not to treat any cond…
Matched conditions: BIOEQUIVALANCE
Phase: PHASE1 • Sponsor: ADIUM • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Progesterone showdown: are two injections equally effective?
Knowledge-focused CompletedThis study tested whether a new injectable progesterone (Prontogest) works the same in the body as the standard progesterone injection. Twenty-six healthy postmenopausal women received single doses of each in a randomized order. The goal was to check if the two formulations are b…
Matched conditions: BIOEQUIVALANCE
Phase: PHASE1 • Sponsor: Zi Diligence Biocenter • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Generic diabetes pill matches brand in healthy volunteer test
Knowledge-focused CompletedThis study tested whether a generic version of empagliflozin (25 mg) works the same as the brand-name drug Jardiance® in 32 healthy adults. Participants took a single dose of each tablet under fasting conditions, and researchers measured drug levels in the blood to check for bioe…
Matched conditions: BIOEQUIVALANCE
Phase: NA • Sponsor: ADIUM • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
New trazodone formula tested for similarity to current version
Knowledge-focused CompletedThis study tested whether a new polymer version of the antidepressant trazodone (150 mg and 300 mg tablets) is absorbed in the body the same way as the current Contramid® version. Sixty-four healthy adults took both forms in a crossover design to measure drug levels in the blood.…
Matched conditions: BIOEQUIVALANCE
Phase: PHASE1 • Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:07 UTC